CVE:KHRN Khiron Life Sciences (KHRN) Stock Price, News & Analysis C$0.04 0.00 (0.00%) As of 05/5/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Khiron Life Sciences Stock (CVE:KHRN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Khiron Life Sciences alerts:Sign Up Key Stats Today's RangeC$0.04▼C$0.0550-Day RangeC$0.04▼C$0.0452-Week RangeC$0.04▼C$0.21Volume24,000 shsAverage Volume256,268 shsMarket CapitalizationC$9.30 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada. Read More Receive KHRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address KHRN Stock News HeadlinesPharmadrug Stock (OTC:LMLLF), Quotes and News SummaryMay 23, 2024 | benzinga.comFocus: Colombia's cannabis industry in crisis over regulatory, political hurdlesDecember 21, 2023 | msn.comTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.August 8 at 2:00 AM | Porter & Company (Ad)Global Cannabis Co. Trading Lower On Announcing Amended European Business Sale DealNovember 17, 2023 | benzinga.comKhiron Life Sciences Announces Update to the Proposed Sale of Its European BusinessNovember 16, 2023 | finance.yahoo.comClosing Bell: Khiron Life Sciences Corp WT up on Friday (KHRN-WT)May 24, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp down on Monday (KHRN)May 20, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT down on Tuesday (KHRN-WT)May 4, 2023 | theglobeandmail.comSee More Headlines KHRN Stock Analysis - Frequently Asked Questions How have KHRN shares performed this year? Khiron Life Sciences' stock was trading at C$0.04 at the beginning of 2025. Since then, KHRN stock has increased by 0.0% and is now trading at C$0.04. How do I buy shares of Khiron Life Sciences? Shares of KHRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Khiron Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Khiron Life Sciences investors own include Khiron Life Sciences (KHRNF), Aurora Cannabis (ACB), Alpha Lithium (APHLF), Curaleaf (CURLF), HEXO (HEXO), Intel (INTC) and Neptune Wellness Solutions (NEPT). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:KHRN CIKN/A Webwww.khiron.ca Phone705-527-3564FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$46.80 million Net Margins-258.92% Pretax MarginN/A Return on Equity-68.62% Return on Assets-20.79% Debt Debt-to-Equity Ratio6.68 Current Ratio3.08 Quick Ratio0.72 Sales & Book Value Annual SalesC$18.08 million Price / Sales0.51 Cash FlowC$0.01 per share Price / Cash Flow6.67 Book ValueC$0.20 per share Price / Book0.20Miscellaneous Outstanding Shares232,409,000Free FloatN/AMarket CapC$9.30 million OptionableNot Optionable Beta2.64 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (CVE:KHRN) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Khiron Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Khiron Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.